EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study

Dong Liu, Huan-Wei Liang, Yang Liu, Wei Huang, Xin-Bin Pan iD

Diseases of the Esophagus · 2025

DOI: 10.1093/dote/doaf017 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Dong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Therapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoadjuvant Therapy, Chemoradiotherapy, Adjuvant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare the causes of death in patients with locally advanced esophageal cancer treated with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed by surgery. Materials and methods A retrospective cohort study was conducted on patients with stage T3-4aN0M0/T1-4aN1-3 M0 esophageal cancer who underwent either neoadjuvant chemotherapy or neoadjuvant chemoradiotherapy followed by surgery. Overall survival (OS) and specific causes of death were analyzed and compared between the two treatment groups.

Results

A total of 4528 patients were included: 333 (7.4%) received neoadjuvant chemotherapy, and 4195 (92.6%) underwent neoadjuvant chemoradiotherapy. The 5-year OS was comparable between the two groups, both before (42.4% vs. 39.7%; hazard ratio [HR] = 1.14, 95% confidence interval [CI]: 0.98-1.33; P = 0.097) and after (42.2% vs. 42.2%; HR = 1.07, 95% CI: 0.86-1.31; P = 0.567) propensity score matching. The cumulative 5-year absolute risk of death from esophageal cancer (49.9% vs. 50.6%, P = 0.470), death from non-tumor causes (7.8% vs. 9.7%, P = 0.160), death due to lung causes (2.8% vs. 1.4%, P = 0.432), and death from heart-related causes (2.2% vs. 2.0%, P = 0.524) were similar between the two treatment groups.

Conclusion

In patients with locally advanced esophageal cancer, OS and the causes of death were comparable between those receiving neoadjuvant chemotherapy and those undergoing neoadjuvant chemoradiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoadjuvant TherapyChemoradiotherapy, AdjuvantHumansRetrospective StudiesMaleFemaleMiddle AgedAgedCause of DeathEsophagectomyNeoplasm StagingChemotherapy, AdjuvantChemoradiotherapyPropensity Score

Stichwörter der Autor:innen

Causes of deathEsophageal cancerNeoadjuvant chemoradiotherapyNeoadjuvant chemotherapyOverall survival

Autor:innen und Institutionen

  • Department of Radiation Therapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, No. 150 Dongfang Road, Qiantang District, Hangzhou, Zhejiang 310018, P.R. China.
  • Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Qingxiu District, Nanning, Guangxi 530021, P.R. China.

ORCID-Profile: Xin-Bin Pan

Zitieren

APA

Liu, D., Liang, H. W., Liu, Y., Huang, W., & Pan, X. B. (2025). Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf017

Vancouver

Liu D, Liang HW, Liu Y, Huang W, Pan XB. Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf017

BibTeX
@article{Liu2025,
  author = {Liu, Dong and Liang, Huan-Wei and Liu, Yang and Huang, Wei and Pan, Xin-Bin},
  title = {Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study},
  journal = {Diseases of the Esophagus},
  year = {2025},
  doi = {10.1093/dote/doaf017}
}
Kostenlos starten →